Samsung BioLogics reaches milestone with FDA nod for production of mAb at South Korean plant

26th July 2018 Uncategorised 0

South Korea’s quickly growing biologics CDMO, Samsung BioLogics, has won FDA approval for its first finished product at the second of three plants that have been built in rapid succession.  

More: Samsung BioLogics reaches milestone with FDA nod for production of mAb at South Korean plant
Source: fierce